Announcements
Updates on company’s negotiable securities for investors’ information
1.Date of occurrence of the event: Mar 23, 2020 2.Cause of occurrence: Notified by Taipei Exchange (TPEx) to release information 3.Financial and business information: (1 ) Latest 1 month SUBJECT …
Announcement on change of accountant due to internal adjustment of accounting firm
Date of occurrence of the event: Mar 13, 2020 Name of the original accounting firm and name of the original CPA: PwC Taiwan, Yu-Kuan Lin; PwC Taiwan, Sheng-Wei Deng Name …
The Board of Directors resolved to hold 2020 Annual General Meeting
Date of the board of directors resolution: Mar 13, 2020 Date for convening the shareholders’ meeting: Jun 22, 2020 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …
The board of directors have resolved not to distribute dividends for 2019
Date of the board of directors resolution: Mar 13, 2020 Year or quarter which dividends belong to : 2019 Period which dividends belong to: Jan 01, 2019 to Dec 31, …
Board of Directors approved the Company’s 2019 financial statement
Date of occurrence of the event: Mar 13, 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: Not …
Clarification on News Article by Economy Daily News
Date of occurrence of the event: Mar 12, 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: Not …
OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities
1.Date of the event: Mar 11, 2020 2.Time: 14:30:00 NST 3.Location: Taipei New Horizon (Address: 6F., No. 88, Yanchang Rd., Xinyi Dist., Taipei City 110, Taiwan) 4.Summary: OBI Pharma Inc. …
Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Gastric Cancer
Date of occurrence of the event: Jan 18, 2020 Company name: OBI Pharma, Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: Not …
OBI Pharma Inc. to attend The 38th Annual J.P. Morgan Healthcare Conference
1.Date of the event: Jan 16, 2020 2.Time: 05:30:00 NST 3.Location: Westin St. Francis Hotel, San Francisco, California 4.Summary: OBI Pharma Inc. to attend The 38th Annual J.P. Morgan Healthcare …
Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Pancreatic Cancer
Date of occurrence of the event: Dec 24, 2019 Company name: OBI Pharma, Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: Not …